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Summary
Vibrio cholerae causes the severe diarrhoeal disease
cholera. A cascade of regulators controls expression
of virulence determinants in V. cholerae at both tran-
scriptional and post-transcriptional levels. ToxT is the
direct transcription activator of the major virulence
genes in V. cholerae. Here we describe TarA, a highly
conserved, small regulatory RNA, whose transcrip-
tion is activated by ToxT from toxboxes present
upstream of the ToxT-activated gene tcpI. TarA regu-
lates ptsG, encoding a major glucose transporter in
V. cholerae. Cells overexpressing TarA exhibit
decreased steady-state levels of ptsG mRNA and
grow poorly in glucose-minimal media. A mutant
lacking the ubiquitous regulatory protein Hfq
expresses diminished TarA levels, indicating that
TarA likely interacts with Hfq to regulate gene
expression. RNAhybrid analysis of TarA and the puta-
tive ptsG mRNA leader suggests potential productive
base-pairing between these two RNA molecules. A V.
cholerae mutant lacking TarA is compromised for
infant mouse colonization in competition with wild
type, suggesting a role in the in vivo fitness of V.
cholerae. Although somewhat functionally analogous
to SgrS of Escherichia coli, TarA does not encode a
regulatory peptide, and its expression is activated by
the virulence gene pathway in V. cholerae and not by
glycolytic intermediates.
Introduction
Asiatic cholera, a severe diarrhoeal disease, remains a
significant cause of morbidity and mortality in many
regions of the globe (Sack et al., 2006). Cholera is caused
by ingestion of the Gram-negative, highly motile curved
bacillus Vibrio cholerae in contaminated food or water. V.
cholerae are present in many coastal areas worldwide;
however, of the hundreds of known V. cholerae sero-
groups, only the O1 and O139 serogroups can cause
cholera (Reidl and Klose, 2002; Sack et al., 2004).
The two major V. cholerae virulence factors are the
cholera toxin (CT) and the toxin-coregulated pilus (TCP).
Secretion of CT into the intestinal lumen by V. cholerae
directly causes the secretory diarrhoea characteristic of
cholera (Lonnroth and Holmgren, 1973; Gill, 1976). The
genes encoding the two subunits of CT, ctxAB, are
located within the genome of a filamentous bacterioph-
age, CTXF (Waldor and Mekalanos, 1996). The TCP, a
type IV bundle-forming pilus, is required for intestinal
colonization by V. cholerae and acts to initiate micro-
colony formation (Taylor et al., 1987; Herrington et al.,
1988; Attridge et al., 1996; Thelin and Taylor, 1996). The
genes encoding TCP are located within the Vibrio patho-
genicity island (VPI), which may also be a mobile
element but is not a bacteriophage (Manning, 1997;
Karaolis et al., 1998; Faruque and Mekalanos, 2003;
Rajanna et al., 2003). Other putative virulence genes
located within the VPI are coordinately regulated with
ctxAB and tcp, but their roles in pathogenesis are
unclear.
Expression of genes encoding V. cholerae virulence
factors is regulated by a cascade involving transcription
activators, repressors and proteases (Matson et al.,
2007); however, the direct transcription activator of viru-
lence genes is ToxT (Matson et al., 2007). ToxT is a
member of the AraC/XylS family of transcription factors
(Higgins et al., 1992; Ogierman and Manning, 1992). ToxT
binds to a 13 bp degenerate DNA sequence, the toxbox,
to activate transcription (Withey and DiRita, 2006), using
toxboxes configured as direct repeats, inverted repeats,
and single toxboxes to activate transcription of different
operons (Withey and DiRita, 2005a; 2006).
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Binding sites for ToxT have been characterized at most
of the promoters it is known to activate (Withey and
DiRita, 2005a,b; 2006). An exception is the tcpI promoter,
located on the VPI and encoding a putative methyl-
accepting chemotaxis protein with an unknown role in
pathogenesis (Harkey et al., 1994). Our sequence analy-
sis identified two pairs of putative toxboxes upstream of
tcpI; one pair, in an inverted configuration, is positioned
proximal to the tcpI open reading frame (Withey and
DiRita, 2006). The other pair, in a direct repeat configura-
tion, is positioned at a site upstream of the proximal tox-
boxes (Fig. 1A), and thus we refer to them as the distal
toxboxes. Primer extension analysis performed previously
by others identified two different start sites of tcpI tran-
scription that would potentially correspond to transcription
activated by ToxT from each set of toxboxes, although
when those studies were carried out, the toxboxes had
not yet been identified (Thomas et al., 1995; Murley et al.,
2000). We performed experiments to characterize the role
of ToxT in transcription from both of these putative sites
and have found that there are indeed two separate ToxT-
dependent transcripts produced upstream of tcpI.
However, the tcpI-proximal promoter alone is responsible
for transcription of tcpI itself (J.H. Withey and V.J. DiRita,
unpublished).
Here we describe a small RNA (~91 nt), which we
named TarA for ToxT-activated RNA, whose transcription
from a gene located between tcpI and tcpP is activated by
ToxT at the promoter distal to tcpI. The TarA nucleotide
sequence is highly conserved among both epidemic and
environmental V. cholerae strains that carry the VPI. We
demonstrate that TarA influences glucose uptake through
its effect on the transcript encoding the glucose trans-
porter PtsG.
Results
ToxT activates transcription of a small non-coding RNA
To characterize ToxT-dependent activation of tcpI, we
constructed lacZ fusions and assayed b-galactosidase
activity in V. cholerae having either wild-type toxT or a
toxT deletion. Our results indicated that the minimal ToxT-
responsive DNA sequence for activating a tcpI–lacZ
fusion at this tcpI-proximal promoter extended only to -94
relative to the proximal tcpI promoter. Because a second
separate start site for tcpI transcription had been previ-
ously described at -243 relative to the AUG (Harkey et al.,
1994; Murley et al., 2000), we also constructed tcpI::lacZ
fusions extending to -431 relative to the start site of
transcription from the tcpI-proximal promoter to include
both putative promoters (Fig. 1A). However, additional
upstream DNA, even if it contained the putative tcpI-distal
promoter, did not affect the level of b-galactosidase
produced. This result suggested that the distal promoter, if
functional, does not read into tcpI under the conditions
tested.
To determine whether the tcpI-distal promoter is func-
tional, we created a set of lacZ fusions whose 3′ endpoints
were located upstream of the tcpI-proximal promoter (at
-173 relative to its start site and +36 relative to the distal
promoter start site) and with 5′ endpoints that extended to
-59, -81 or -223 relative to the start of transcription from
the distal promoter (Fig. 1B). Results of b-galactosidase
assays using these constructs indicated that the tcpI-
distal promoter was indeed functional and highly activated
by ToxT (Table 1). Sequence analysis identified two con-
sensus toxboxes configured as a direct repeat upstream
of the tcpI-distal promoter -35 box that had the same
spacing as the toxboxes we observed at the tcpA pro-
moter (Withey and DiRita, 2006) (Fig. 1B). Deletion of one
of the two toxboxes resulted in a complete loss of ToxT-
directed transcription from the tcpI-distal promoter
[Table 1, Fig. 1B (-59 construct)].
Downstream of the start site of transcription is a G/C rich
region that could potentially form a stem-loop structure
(boxes in Fig. 1B), followed by a tract of T nucleotides on
Fig. 1. Schematic and diagram of tcpI promoters and the
surrounding region.
A. Schematic. Scale bar: 0.5 cm represents 200 bp of DNA. Bent
arrows indicate putative transcriptional start sites, and long black
arrows represent coding sequences of the known genes tcpP and
tcpI. tcpI has been shortened from 1.6 kb for clarity. Toxboxes, or
ToxT-recognition sequences, are indicated by paired boxes.
B. Diagram of tcpI-distal promoter, tarA, and surrounding
sequences. Bent arrows indicate transcriptional start sites for tcpP
and tarA. Numbers indicate position relative to tarA transcriptional
start site. ToxT binding sites (toxboxes) for the tcpI-distal promoter
are underlined with horizontal arrows. The -35 and -10 elements
for tarA are indicated by thick boxes, and thin boxes represent
potential base-pairing regions in putative hairpin structure.
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the non-template strand, suggesting the presence of a
transcription terminator. To determine if a small RNA
product initiating at the tcpI-distal promoter and ending at
the putative terminator is produced, we performed North-
ern blots on whole-cell RNA purified from V. cholerae
having a wild-type or a deleted toxT gene, probing with an
oligonucleotide complementary to the putative sRNA
sequence. A single RNA product of the expected size,
< 100 nt, was detected in the Northern blotting experi-
ments (Fig. 2). Production of the sRNA required functional
ToxT, was detectable beginning at 3 h of growth (data not
shown), continued through logarithmic phase, and peaked
at 7 h of growth under ToxT-inducing conditions; no TarA
was detected in non-inducing conditions (Fig. 2). These
findings are consistent with previous observations of ToxT
activity (Yu and DiRita, 1999). Based on this evidence, we
named this previously unknown sRNA ‘TarA’ for ToxT-
Activated RNA. TarAcontains a putative binding site for the
ubiquitous regulatory protein Hfq and lacks an open
reading frame; thus, its function is likely to be regulatory.
TarA is highly conserved among V. cholerae strains
To determine whether TarA has homology to any other
sRNA species, we performed searches with its sequence
from the classical V. cholerae strain O395 using both the
RNAfam database and BLAST (Touzet and Perriquet,
2004). The former search indicated that TarA has no
homology to any known sRNA family. However, the latter
search indicated that TarA has a very high degree of
sequence conservation among V. cholerae (Table 2,
Fig. 3). TarA sequences from eight different V. cholerae
strains were obtained from the BLAST search; two of these
are classical biotype V. cholerae, two are El Tor biotype V.
cholerae and four are non-O1 V. cholerae. The two clas-
sical strains have identical TarA sequences and the
sequences of the two El Tor strains are also identical
Table 1. Nested tarA::lacZ fusion analysis.
5′ Endpoint 3′ Endpoint
Miller units
(wild-type toxT) Miller units (DtoxT)
Fold difference
(toxT/DtoxT)
-223 +36 11 800  500 804  137 15¥
-81 +36 18 000  551 436  44.8 41¥
-59 +36 94.6  9.35 93.1  16.5 1¥
5′ and 3′ endpoints indicate region of V. cholerae chromosome ligated into pTL61T plasmid. Fusion plasmids were electroporated into wild-type
O395 and an isogenic DtoxT strain. Cultures were grown under inducing conditions for 3 h and then tested for b-galactosidase activity, with data
reported in Miller units. Fold difference was determined by taking the ratio of wild-type activity to DtoxT activity.
Table 2. Conservation of TarA and upstream sequences.
V. cholerae strain Biotype O antigen TarA conservation
Upstream DNA
conservation
O395a Classical O1 99/99 nt 99/99 bp
Z17561a Classical O1 99/99 nt 99/99 bp
N16961a El Tor O1 96/99 nt 62/99 bp
H1a El Tor O1 96/99 nt 75/99 bp
SCE4 Environmental O8 99/99 nt 75/99 bp
SCE200a Environmental O44 99/99 nt 91/99 bp
SCE256 Environmental O42 99/99 nt 68/99 bp
SCE226 Environmental O35 98/99 nt 85/99 bp
a. Toxigenic strain.
100 nt





















LB pH 6.5, 30°C        LB pH 8.5, 37°C
Fig. 2. TarA is produced under ToxT-inducing conditions.
Wild-type and DtoxT strains were grown under inducing and
non-inducing conditions (LB pH 6.5, 30°C and LB pH 8.5, 37°C
respectively) and total RNA was collected at indicated time points.
Equal amounts of RNA from each sample (as determined by OD260)
were subjected to Northern blot analysis, using an oligonucleotide
complementary to the putative sRNA sequence as a probe.
Methylene blue staining was used to confirm load amounts (data
not shown).
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(Table 2 and Fig. 3). However, the El Tor sequences have
a single nucleotide insertion and two substitutions that
differ from the classical sequences. The non-O1 V. chol-
erae strains, commonly known as environmental V. chol-
erae to distinguish them from the O1 epidemic strains,
carry the VPI but are not capable of causing cholera.
These environmental V. cholerae strains have TarA
sequences apparently derived from the classical biotype
or vice versa. Three of these four non-O1 strains have
TarA sequences identical to the classical TarA sequences;
the fourth non-O1 strain has a single nucleotide change
from the classical TarA sequences at a position that differs
from the changes observed between classical and the El
Tor biotype strains.
To determine whether the degree of TarA sequence
conservation among different V. cholerae strains is a
general feature of the VPI, we compared the DNA
sequences 99 bp directly upstream of the tarA start site in
the above strains to the sequence in O395. This analysis
indicated that the tarA sequence was preferentially con-
served over the surrounding intergenic sequence
(Table 2). The degree of conservation of the 99 bp directly
upstream of tarA varies to a wide degree, even between
strains that have identical tarA sequences. For example,
classical O395 and environmental SCE 256 have 99/99
identical base pairs within the tarA gene but only 68/99
identical base pairs within the upstream sequence. These
upstream 99 bp include both the promoter and the two
toxboxes that are required for expression of tarA; notably,
the toxbox sequences are 100% conserved in every
strain. We have also observed TarA expression in the El
Tor strain N16961 under ToxT-inducing conditions (data
not shown). These results strongly suggest that TarA
conveys an evolutionary advantage to both environmental
and epidemic V. cholerae and that its regulation by ToxT is
highly conserved.
TarA regulates ptsG mRNA levels in V. cholerae
To identify potential regulatory targets of TarA, we probed
microarrays of the V. cholerae genome with RNA isolated
from classical strain O395 and its DtarA derivative. The
DtarA strain features a markerless deletion of the
91-nucleotide RNA sequence with the promoters left
intact. The whole-genome expression data were analysed
using the Significance Analysis of Microarrays (SAM)
program (Tusher et al., 2001) using  2.0-fold differences
in gene expression and a  1% false discovery rate
(FDR) as cut-off values. A gene annotated as ptsG
(VC2013 in the N16961 genome sequence) was upregu-
lated by greater than twofold in the DtarA strain compared
with wild type. This is consistent with a previous microar-
ray study (Bina et al., 2003), in which VC2013 RNA was
shown to be upregulated in DtoxT V. cholerae relative to
wild type. This pattern of regulation – with VC2013
expression being negatively controlled by ToxT – is in
contrast to that of nearly all other known ToxT-regulated
genes, such as the toxin co-regulated pilus (tcp) and the
cholera toxin (ctxAB), which are positively controlled by
ToxT. That ptsG may be the target of sRNA regulation in V.
cholerae is consistent with the fact that ptsG in Escheri-
chia coli is also regulated by a small RNA, SgrS (Vander-
pool and Gottesman, 2004).
To confirm the microarray result, we used quantitative
real-time polymerase chain reaction (qRT-PCR) compar-
ing ptsG mRNA levels in wild type and tarA mutant V.
cholerae strain O395. Consistent with the microarray
experiments, we observed an approximately threefold
increase in ptsG mRNA in mutant cells compared with wild
type (Fig. 4), supporting the hypothesis that TarA acts to
decrease the levels of ptsG mRNA. To be sure that regu-
lation was due to the specific absence of tarA and not due
to a polar effect on tcpI, a DtcpI strain was also tested.
ptsG transcript levels in the DtcpI strain closely resemble
those seen in wild-type O395, ruling out this possibility.
Growth of V. cholerae in minimal glucose medium is
limited in cells overexpressing TarA
In E. coli, SgrS acts to reduce ptsG mRNA levels and to
limit glucose uptake under conditions where flux through
the glycolytic pathway may be disrupted, thereby allowing
the accumulation of potentially lethal phospho-glucoside
compounds (Vanderpool and Gottesman, 2004). When E.
coli is grown with the glucose analogue alpha-methyl-










Fig. 3. Comparison of tarA sequences among V. cholerae strains. Sequences from strains indicated in Table 2 are aligned, with bold letters
indicating mutations. The box indicates a conserved potential Hfq binding site.
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taken up by PtsG, but phospho-aMG cannot be catabo-
lized by the normal glucose metabolic pathway and
therefore accumulates. Under such conditions, sgrS
expression is induced and the resulting degradation of
ptsG mRNA reduces further uptake of aMG. Mutants
lacking sgrS are highly sensitive to aMG (Vanderpool and
Gottesman, 2004). We tested whether DtarA V. cholerae
exhibited enhanced sensitivity to aMG relative to wild
type, which would be a physiological consequence of the
fact that TarA regulates ptsG mRNA in V. cholerae. The
two strains were grown in LB supplemented with aMG in
concentrations ranging from 1% to 10% weight by
volume; we did not see a consistent effect of this glucose
analogue on DtarA V. cholerae at any of the concentra-
tions tested.
Failing to identify an aMG effect, we tested another
ptsG-related hypothesis. We reasoned that constitutive
overexpression of TarA, which would remove the RNA
from its normal regulation by ToxT, would affect the growth
physiology of V. cholerae, leading to diminished growth in
glucose-containing minimal media if indeed ptsG mRNA
levels are regulated by TarA. Overexpression of TarA in
LB-grown V. cholerae had a slight effect on culture growth
rate, although the final optical density achieved by this
culture was close to wild type. Growth of DtarA and wild-
type V. cholerae carrying the vector alone was unaffected
compared with wild type (Fig. 5A). However, after dilution
from LB into minimal MOPS/0.5% glucose media, the
cells overexpressing TarA were severely deficient for con-
tinued growth and resembled the DptsG strains, while the
other strains grew similarly after a lag phase of approxi-
mately 3 h (Fig. 5B). The DptsG strain complemented with
a constitutively expressed copy of ptsG exhibited partially
restored growth in this medium. Analysis of glucose
remaining in the supernatants of these cultures revealed
similar levels of glucose for approximately 4 h, after which
the culture overexpressing TarA and that of the DptsG















Fig. 4. Confirmation of ptsG regulation by qRT-PCR analysis.
Cultures of the listed strains were grown under ToxT-inducing
conditions for 7 h and total RNA was isolated using TRIzol. cDNA
was prepared from equivalent amounts of RNA for each sample,
and cDNA was used for SYBR Green qRT-PCR. Numbers indicate
fold change in transcript level between strains, calculated using the
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Fig. 5. Overexpression of TarA results in severely reduced
glucose uptake.
A. LB growth. Indicated strains were grown overnight in LB media,
subcultured into fresh LB and grown to mid-exponential phase,
then washed with PBS and diluted into fresh LB to OD = 0.04.
Cultures were grown in a 96-well plate at 30°C with constant
aeration, and the OD600 was measured every 20 min. Growth
assays were performed at least three times, and a representative
growth curve is shown.
B. MOPS/glucose growth. Strains were prepared as in (A), but
diluted into MOPS/0.5% glucose instead of LB and then grown as
in (A). Growth assays were performed at least three times, and a
representative growth curve is shown.
C. Strains were grown overnight in LB, subcultured into LB and
grown to mid-exponential phase, then washed and diluted into
MOPS/0.5% glucose, and grown in flasks. At specified time points,
supernatants were collected and the glucose concentration was
tested using a tetrazolium blue-reducing sugar assay. Calculated
glucose concentrations were divided by the starting concentration
to determine the amount of glucose remaining in the media. This
experiment was performed three times, and a representative assay
is shown. Error bars indicate the standard deviation among
triplicate samples in the representative experiment.
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mutants nearly stopped removing glucose from the
medium while the others continued to do so (Fig. 5C).
Thus, the poor growth of wild-type cells overexpressing
TarA correlated with decreased levels of glucose uptake,
similar to cells lacking ptsG.
To more carefully examine the association between
TarA and ptsG mRNA levels, we placed tarA expression
under control of an IPTG-inducible promoter in pHDB3
and followed steady-state levels of ptsG mRNA message
upon TarA induction. DtarA V. cholerae carrying this
plasmid were grown in LB to mid-logarithmic levels before
addition of IPTG to induce tarA expression. Thirty minutes
after IPTG induction, cells were collected, washed, resus-
pended in fresh media and allowed to continue growing
for another 30 min. RNA was harvested from cells at 0, 2,
10 and 30 min after addition of IPTG, and then at 10 and
30 min after the IPTG was washed out. RNA was analy-
sed by Northern blotting using a probe specific for TarA or
ptsG mRNA.
Prior to induction (0 min) TarA was undetectable while
ptsG mRNA was abundant. Within 2 min after induction by
IPTG, TarA became detectable and the amount of ptsG
mRNA diminished. This continued throughout the course
of the experiment, with TarA expression remaining at high
levels and ptsG mRNA detectable at levels considerably
lower than those seen prior to induction (Fig. 6). Cells
carrying the cloning vector alone expressed no detectable
TarA and very high levels of ptsG mRNA. The levels of
ptsG mRNA were higher in the strain carrying only the
cloning vector than in the cells carrying the tarA clone
without induction, which could be due to undetectable yet
functional levels of TarA being expressed even prior to
addition of IPTG. There is a slight decrease in ptsG mRNA
levels in the vector control after 30 min of induction and
10 min of washout (t = 40 time point), which we attribute to
transcript turnover as the cells near stationary phase.
Base complementarity between TarA and the 5 region
of the ptsG mRNA
In E. coli, SgrS controls ptsG transcript levels in part by
associating with the 5′ end of the ptsG mRNA and causing
its degradation in a process that depends on Hfq and
RNase E (Wadler and Vanderpool, 2007; Maki et al.,
2008). We used the alignment prediction program RNAhy-
brid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/
welcome.html) to identify potential areas of com-
plementarity between TarA and the leader sequence of
the ptsG transcript that would be expected for a similar
mechanism to be operating in V. cholerae. This program
produced a structure with a favourable free energy
(-54.4 kcal mol-1) and a predicted unpaired region, which
includes the putative Hfq binding site (Fig. 7). For pur-
poses of comparison, we tested the potential complemen-
tarity of SgrS and the 100 bp directly upstream of ptsG in
E. coli with the same program, which yielded a similarly
composed structure with a minimal free energy of
-49.2 kcal mol-1 (data not shown).
TarA is unstable in the absence of Hfq
Given the putative Hfq binding site in the TarA sequence,
we hypothesized that TarA interacts with Hfq. It is well
established that Hfq-interacting small RNAs are markedly
less stable in the absence of Hfq (Sledjeski et al., 2001;
Moller et al., 2002; Masse et al., 2003; Moll et al., 2003;
Morita et al., 2004; Kawamoto et al., 2005). To explore a
potential TarA/Hfq interaction, we assessed TarA levels by
Northern blot analysis of RNA from wild type and hfq
mutant V. cholerae. Cells were grown for 7 h in ToxT-
inducing conditions prior to RNA isolation and blotting. As
predicted, the hfq mutant had significantly reduced TarA
RNA in comparison with the wild-type strain O395 (Fig. 8).
Discussion
Here we describe a small, non-coding regulatory RNA,
TarA, whose transcription is directly activated by the major
V. cholerae virulence activator protein ToxT. Activation of a
regulatory RNA by ToxT adds another level to the complex
V. cholerae virulence regulatory cascade and contributes
to our understanding of ToxT-dependent gene activation.
Based on our previous analyses of other ToxT-activated
genes, the promoter architecture of tarA most closely
       TarA 
   0     2    10   40    0     2    10   40
TarA vector







Fig. 6. Induction of TarA reduces ptsG transcript levels. Strains
AR059 and AR060, containing an IPTG-inducible copy of TarA and
an empty vector control, respectively, were grown overnight in LB.
Cultures were diluted 1:200 into fresh LB, grown until OD ~0.4, and
stimulated with IPTG. Thirty minutes after induction, cultures were
washed and resuspended in fresh media lacking IPTG. RNA was
collected at indicated time points (from the start of induction) using
TRIzol, and equal amounts of RNA for each sample were subjected
to Northern blot analysis. Methylene blue staining was used to
confirm load amounts (not shown). Blots were probed with
oligonucleotides complementary to TarA (A) and to the ptsG
transcript (B).
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resembles that of tcpA (Withey and DiRita, 2006). Fur-
thermore, the degree of activation conferred by ToxT to
the two genes is very similar – 41-fold for tarA and 44-fold
for tcpA. The two tarA toxboxes have 7/7 and 6/7 of the
toxbox core determinants conserved (Matson et al.,
2007), the highest match to consensus we have observed
for any operon having two toxboxes. However, while the
degree of ToxT activation of tarA is very high, it is not
higher than the ToxT activation of tcpA, which has a
poorer match to consensus at one toxbox. This suggests
that the toxbox sequences may have evolved to be maxi-
mally efficient at any given locus, such that surrounding
sequence that is not conserved in the consensus align-
ment plays a more important role than previously thought.
TarA joins a growing list of regulatory sRNAs in V.
cholerae. Four sRNAs, Qrr1, 2, 3 and 4, are involved in
regulating the quorum-sensing response, together with
Hfq protein, by negatively affecting the stability of hapR
mRNA (Lenz et al., 2004). Another three sRNAs, CsrB, C,
D, are also involved in quorum sensing; these act to inhibit
activity of CsrA protein, which subsequently leads to
expression of the Qrr sRNAs (Lenz et al., 2005). Another
sRNA is RyhB, which is involved in regulating iron-
containing proteins (Davis et al., 2005). RyhB acts with
Hfq to destabilize the mRNAs encoding these proteins.
While many other sRNAs have been described in E. coli,
very few of these are conserved in V. cholerae. The
exceptions are SsrA, also known as tmRNA, RnpB, Spf
and Ffs (Livny and Waldor, 2007). Recently, large
numbers of sRNAs have been identified in V. cholerae
using bioinformatics and parallel sequencing methods
(Vogel et al., 2003; Livny et al., 2008). One of these,
IRG7, also contributes to regulation of carbon utilization
by negatively regulating a mannitol transport gene, mtlA
(Liu et al., 2009). TarA was not identified in either of these
studies.
Our results suggest that a target of negative regulation
by TarA in V. cholerae is ptsG, encoding a glucose trans-
porter in the phosphotransferase system. In E. coli, ptsG
is negatively regulated by SgrS, an sRNA whose mecha-
nisms of action have been the subject of a significant
amount of research. Expression of sgrS is activated by a
conserved regulatory protein called SgrR, in response to
glucose-phosphate stress (Vanderpool and Gottesman,
2004). SgrS is a bifunctional molecule, postulated to
inhibit PtsG through two distinct mechanisms. One is by
acting as a regulatory RNA directly by participating in a
ternary complex with Hfq and the ptsG mRNA through








Fig. 7. Alignment of TarA and ptsG upstream sequences. The
program RNAhybrid
(http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/welcome.html) was
used to predict potential base-pairing between TarA and the ptsG
leader sequence (defined here as 100 bp upstream of the AUG,
including the +1 A). The TarA sequence is shown in green and the
ptsG leader sequence in red. The putative Hfq binding site is










Fig. 8. TarA is unstable in the absence of Hfq. Wild type, DtarA
and Dhfq strains were grown under inducing conditions (LB pH 6.5,
30°C) and total RNA was collected after 7 h of growth. Equal
amounts of RNA from each sample (as determined by OD260) were
subjected to Northern blot analysis, using an oligonucleotide
complementary to TarA as a probe. Methylene blue staining was
used to confirm load amounts (data not shown).
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The site on ptsG mRNA that is base-paired to SgrS is in
the 5′ end of the transcript at the Shine–Dalgarno
sequence (Vanderpool and Gottesman, 2004), blocking
translation and eventually leading to degradation of ptsG
mRNA through a mechanism that requires RNase E (Maki
et al., 2008). We think it likely that TarA also acts in a
similar fashion, given the base complementarity between
TarA and ptsG RNA, overlapping the latter’s Shine–
Dalgarno site. AU-rich sequences within a predicted
unpaired region of TarA may also correspond to an Hfq-
binding domain (Fig. 7) (Link et al., 2009). Our observa-
tion that TarA is less stable in an hfq mutant lends support
to our hypothesis that Hfq and TarA interact. The second
mechanism by which SgrS regulates PtsG is through a
small protein, SgrT, encoded at the 5′ end of the same
RNA that includes SgrS in E. coli and in a variety of other
species (Wadler and Vanderpool, 2007) (Horler and
Vanderpool, 2009). SgrT is hypothesized to act post-
translationally on PtsG function (Wadler and Vanderpool,
2007). TarA does not have an open reading frame and is
consequently much shorter than SgrS. Another distinction
between SgrS and TarA is that, unlike functional SgrS
homologues in many other Gram-negative bacteria
(Horler and Vanderpool, 2009), a homologue of the SgrR
regulatory protein is not found encoded next to tarA in the
VPI. As sequence homology to sgrR was used to locate
SgrS functional homologues in other enteric bacteria, the
fact that an SgrS homologue was not predicted in V.
cholerae is not surprising.
Unlike sgrS in E. coli, tarA expression is not controlled
by the glucose-phosphate response regulator SgrR, but
rather by ToxT, the activator responsible for expression of
the major virulence factors of V. cholerae. The high
degree of similarity between the tarA and tcpA toxboxes
suggests that the two are expressed synchronously
during infection. tarA makes a slight contribution to the
fitness of V. cholerae during infection, as competition
experiments between wild type and tarA mutant V. chol-
erae in the infant mouse model resulted in a small but
consistent colonization defect of the tarA mutant (average
competitive index = 0.45). Cells expressing elevated PtsG
during infection could be at a competitive disadvantage if
glucose is not the preferred in vivo carbon source. This
hypothesis is under investigation. An alternative explana-
tion for how the link between tarA expression and viru-
lence gene activation may have evolved comes from work
demonstrating that V. cholerae in stool samples of cholera
patients store glucose in the form of glycogen granules,
and that glycogen biosynthesis genes are expressed late
during infection (Schild et al., 2007). Perhaps tarA expres-
sion by ToxT during infection, with a subsequent reduction
in ptsG mRNA, prepares the cells for the apparent meta-
bolic conversion to glycogen production by reducing the
amount of glucose transported into the glycolytic pathway.
Experimental procedures
V. cholerae strains and plasmids
Strains used in this work were classical V. cholerae O395, El
Tor strain N16961 and derivatives (listed in Table S1). The
DtarA, DptsG and Dhfq strains were constructed from O395
and N16961 by mating with E. coli SM10lpir using the
pKAS32 suicide vector as previously described (Skorupski
and Taylor, 1996). The deletion was confirmed by PCR using
primers flanking the gene. Strains were grown in LB medium
at 37°C (overnight cultures), in LB medium with a starting pH
of 6.5 at 30°C (inducing conditions for classical strains), or
under AKI conditions (inducing conditions for El Tor strains).
Strains were maintained in LB/20% glycerol at -70°C. Anti-
biotics were used in the following concentrations: ampicillin:
100 mg ml-1, streptomycin: 100 mg ml-1 and chloramphenicol:
30 mg ml-1.
Strains used for b-galactosidase assays were either O395
or an O395 DtoxT derivative (VJ740, Champion et al., 1997)
carrying the respective tarA::lacZ fusion in plasmid pTL61T
(Linn and St Pierre, 1990). All constructs were cloned
between the HindIII and XbaI sites of pTL61T. For constitutive
and inducible expression of TarA, plasmids pKK177-3RI
(Opdyke et al., 2004) and pHDB3 (Ulbrandt et al., 1997) were
used, respectively. In pKK177-3RI, the tarA sequence alone
was cloned between the EcoRI and HindIII sites, creating
plasmid pJM292. The tarA sequence preceded by the PLlacO
operator sequence was cloned between the BamHI and
HindIII sites of pHDB3 to generate pAR6. These plasmids,
and the empty vector controls, were electroporated into wild-
type O395 and N16961 (pKK177-3RI and pJM292) and the
corresponding DtarA strains (pHDB3 and pAR6). For ptsG
complementation, the ptsG sequence preceded by a ribo-
some binding site was cloned between the EcoRI and XbaI
sites of pUC19, generating plasmid pAR7. This plasmid and
the empty vector control were then electroporated into
N16961 DptsG. All plasmid sequences were confirmed by the
University of Michigan DNA sequencing core.
b-Galactosidase assays
Strains were cultured overnight in LB medium at 37°C, then
subcultured at a 1/50 dilution into inducing medium and
grown for 3 h at 30°C with vigorous aeration. Bacteria were
then placed on ice and chloramphenicol was added to
0.5 mg ml-1. b-Galactosidase assays were performed using
the basic procedure of Miller (Miller, 1972) as previously
described (Withey and DiRita, 2005b).
DNA manipulations
Plasmids were purified using the Promega Wizard Plus Mini-
prep kit. PCR was performed using Taq DNA polymerase
(Roche) as specified by the manufacturer. Restriction
enzymes were purchased from New England Biolabs and
used as specified by the manufacturer.
Growth analysis and glucose quantification
Strains N16961, AR43, AR38, AR39, AR74, AR80 and AR81
were grown overnight in LB, then subcultured 1:100 into fresh
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LB and grown to mid-log phase (6 h). OD600 was measured
for each culture, and 1 ¥ 109 bacteria of each strain were
pelleted, washed in PBS and resuspended to a final OD600 of
2 in PBS. These suspensions were then diluted 1:50 (final
OD600 = 0.04) into LB and MOPS minimal medium supple-
mented with 0.4% glucose (Neidhardt et al., 1974), and dis-
pensed into a 96-well plate. The plate was incubated at 30°C
with constant shaking for 8 h in an Omega Polarstar plate
reader, with OD600 measured every 20 min. For glucose quan-
tification, cultures were prepared as described and grown in
125 ml flasks on a ThermoFisher orbital shaker at 37°C. One
millilitre of samples were taken at 0, 4 and 8 h of growth.
Bacteria were pelleted, and 10-fold diluted supernatants were
used in a tetrazolium blue-reducing sugar assay as described
(Jue and Lipke, 1985). Glucose concentration was deter-
mined for each sample and divided by the starting concen-
tration to determine the per cent glucose remaining. Assays
were run in triplicate three times.
Northern blots
Whole-cell RNA was purified from O395 and VJ740 (DtoxT) V.
cholerae grown in parallel under inducing and non-inducing
conditions (Fig. 2), from strains AR59 and AR60 after addition
of IPTG (Fig. 6), and from strains O395, AR15 and AR24
grown under inducing conditions (Fig. 8). At specific points
(as detailed in figure legends for each experiment), the OD600
of each culture was read and aliquots of each culture equal to
1 ml of a 0.7 OD600 culture were removed. RNA purification
was performed using the TRIzol reagent as specified by the
manufacturer (Invitrogen). For TarA visualization, 7 mg of total
RNA from each sample was separated by 8% polyacrylamide
gel electrophoresis and transferred to an Amersham Hybond
nylon membrane (GE Healthcare) (0.45 m) with a Semi-Phor
apparatus (Hoefer). An oligonucleotide probe complementary
to nt 12–36 of TarA was radiolabelled with [g-32P]-ATP with T4
polynucleotide kinase (New England Biolabs). Probing con-
ditions were as previously described (Sambrook et al., 1989).
To visualize ptsG transcript, 12.5 mg of each sample was run
on a 1.2% agarose/formaldehyde gel and transferred to an
Amersham Hybond nylon membrane (GE Healthcare). Mem-
branes were probed with an oligonucleotide complementary
to nt 176–208 of the ptsG transcript, labelled as above.
Microarray and qRT-PCR analysis
Cultures of O395 and DtarA strains were grown overnight and
then diluted 1:100 into LB pH 6.5 and grown at 30°C. Once
cultures reached an OD600 ~0.35, they were diluted 1:10 and
grown until OD600 ~0.35 and 2 ml aliquots of the samples
were harvested. Cell pellets were resuspended in TRIzol
(Invitrogen) and total RNA was isolated according to the
manufacturer’s protocol as described previously (Yildiz et al.,
2004). Whole-genome expression analysis was performed
using 70-mer oligos representing the open reading frames
present in the V. cholerae N16961 genome. cDNA synthesis,
microarray hybridization and analysis of expression data
were performed as described previously (Beyhan et al.,
2006) using two biological and four technical replicates (for
each biological replicate).
RNA samples for qRT-PCR were DNase treated, run on an
agarose gel to check quality and quantified by measuring the
OD260. Approximately 2.5 mg of each sample was treated with
Moloney murine leukemia virus (M-MLV) reverse transcriptase
(Invitrogen) according to the manufacturer’s specifications.
For detection of transcripts, primers amplifying a 200 bp
region in the middle of the mRNA were used with SYBR Green
Master Mix (Stratagene) on a Stratagene MX3000P thermocy-
cler. Primers were designed using the OligoPerfect tool (Invit-
rogen). Each test was performed in triplicate at least three
times, and fold change in expression was calculated using the
DDCT method (Pfaffl, 2001), with recA transcript levels used as
controls between cDNA samples.
Infant mouse colonization assays
Four-day-old CD1 mice (Charles River) were inoculated intra-
gastrically with approximately 106 bacteria. The inocula were
50:50 mixtures of the strain of interest (either tarA-/acZ + V.
cholerae or the tarA+/lacZ + control) and the control strain,
which is a lacZ- O395 derivative. Inoculated mice were incu-
bated at 30°C for 16 h, after which the mice were sacrificed
and their intestines were removed and homogenized. Serial
dilutions of the individual intestinal homogenates were plated
on LB agar plates containing streptomycin and X-gal. Blue
and white colonies were counted after overnight growth at
37°C. To determine the ratio of strains in the initial inoculum,
the mixtures used to inoculate the mice were diluted into PBS
and plated onto LB agar plates containing streptomycin and
X-gal, and again the blue and white colonies were counted.
The competitive index was calculated by dividing the
in vivo blue : white ratio by the blue : white ratio of the initial
inoculum.
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